These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33136733)

  • 1. Effect of off-hour versus work-hour thrombolysis for acute ischemic stroke on emergency department patients' outcome: a retrospective study.
    Ozakin E; Ozdemir AO; Aykac O; Cevik AA
    Eur J Emerg Med; 2021 Apr; 28(2):104-110. PubMed ID: 33136733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-hour effect on 3-month functional outcome after acute ischemic stroke: a prospective multicenter registry.
    Kim C; Jang MU; Oh MS; Park JH; Jung S; Lee JH; Yu KH; Han MK; Kim BJ; Park TH; Park SS; Lee KB; Cha JK; Kim DH; Lee J; Kim SH; Lee SJ; Ko Y; Park JM; Kang K; Cho YJ; Hong KS; Cho KH; Kim JT; Kim DE; Choi JC; Jang MS; Bae HJ; Lee BC;
    PLoS One; 2014; 9(8):e105799. PubMed ID: 25165816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On- versus Off-Hour Patient Cohorts at a Primary Stroke Center: Onset-to-Treatment Duration and Clinical Outcomes after IV Thrombolysis.
    Asuzu D; Nystrӧm K; Amin H; Schindler J; Wira C; Greer D; Chi NF; Halliday J; Sheth KN
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):447-51. PubMed ID: 26654664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Within-day and weekly variations of thrombolysis in acute ischemic stroke: results from safe implementation of treatments in stroke-international stroke thrombolysis register.
    Lorenzano S; Ahmed N; Tatlisumak T; Gomis M; Dávalos A; Mikulik R; Sevcik P; Ollikainen J; Wahlgren N; Toni D;
    Stroke; 2014 Jan; 45(1):176-84. PubMed ID: 24262329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation outside office hours does not negatively influence treatment times for reperfusion therapy for acute ischemic stroke.
    Groot AE; de Bruin H; Nguyen TTM; Kappelhof M; de Beer F; Visser MC; Zwetsloot CP; Halkes PHA; de Kruijk J; van der Meulen WDM; van der Ree TC; Kwa VIH; van Schaik SM; Hani L; van den Berg R; Sprengers MES; Roosendaal SD; Emmer BJ; Nederkoorn PJ; Majoie CBLM; Roos YBWEM; Coutinho JM
    J Neurol; 2021 Jan; 268(1):133-139. PubMed ID: 32737653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset.
    Saver JL; Smith EE; Fonarow GC; Reeves MJ; Zhao X; Olson DM; Schwamm LH;
    Stroke; 2010 Jul; 41(7):1431-9. PubMed ID: 20522809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
    Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
    Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Even Faster Door-to-Alteplase Times and Associated Outcomes in Acute Ischemic Stroke.
    Jung S; Rosini JM; Nomura JT; Caplan RJ; Raser-Schramm J
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104329. PubMed ID: 31607439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
    Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
    Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal.
    Nepal G; Yadav JK; Basnet B; Shrestha TM; Kharel G; Ojha R
    BMC Neurol; 2019 Jul; 19(1):155. PubMed ID: 31288770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.